Autophagy Inhibition Potentiates Ruxolitinib-Induced Apoptosis in JAK2V617F Cells

被引：1
|
作者：
Machado-Neto, Joao Agostinho [1 ,2 ]
Coelho-Silva, Juan Luiz [1 ]
de Souza Santos, Fabio Pires [3 ]
Scheucher, Priscila Santos [1 ]
Campregher, Paulo Vidal [3 ]
Hamerschlak, Nelson [3 ]
Rego, Eduardo Magalhaes [1 ,4 ]
Traina, Fabiola [1 ]
机构：
[1] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Internal Med, Ribeirao Preto, Brazil
[2] Univ Sao Paulo, Inst Biomed Sci, Dept Pharmacol, Sao Paulo, Brazil
[3] Albert Einstein Hosp, Einsteins Teaching & Res Inst, Sao Paulo, Brazil
[4] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-119651
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1788
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Autophagy inhibition potentiates ruxolitinib-induced apoptosis in JAK2V617F cells
    Machado-Neto, Joao Agostinho
    Coelho-Silva, Juan Luiz
    de Souza Santos, Fabio Pires
    Scheucher, Priscila Santos
    Campregher, Paulo Vidal
    Hamerschlak, Nelson
    Rego, Eduardo Magalhaes
    Traina, Fabiola
    INVESTIGATIONAL NEW DRUGS, 2020, 38 (03) : 733 - 745
  • [2] Autophagy inhibition potentiates ruxolitinib-induced apoptosis in JAK2V617F cells
    João Agostinho Machado-Neto
    Juan Luiz Coelho-Silva
    Fábio Pires de Souza Santos
    Priscila Santos Scheucher
    Paulo Vidal Campregher
    Nelson Hamerschlak
    Eduardo Magalhães Rego
    Fabiola Traina
    Investigational New Drugs, 2020, 38 : 733 - 745
  • [3] Stathmin 1 inhibition amplifies ruxolitinib-induced apoptosis in JAK2V617F cells
    Machado-Neto, Joao Agostinho
    Campos, Paula de Melo
    Favaro, Patricia
    Lazarini, Mariana
    Santos Duarte, Adriana da Silva
    Lorand-Metze, Irene
    Costa, Fernando Ferreira
    Olalla Saad, Sara Teresinha
    Traina, Fabiola
    ONCOTARGET, 2015, 6 (30) : 29573 - 29584
  • [4] Stathmin 1 Silencing Amplifies Ruxolitinib-Induced Apoptosis in JAK2V617F Cells
    Machado-Neto, Joao Agostinho
    Campos, Paula de Melo
    Favaro, Patricia
    Lazarini, Mariana
    Santos Duarte, Adriana Silva
    Lorand-Metze, Irene
    Olalla Saad, Sara Teresinha
    Traina, Fabiola
    BLOOD, 2014, 124 (21)
  • [5] Clonal architecture of JAK2V617F mutated cells during treatment with ruxolitinib
    Pacilli, Annalisa
    Fanelli, Tiziana
    Mannarelli, Carmela
    Rotunno, Giada
    Pancrazzi, Alessandro
    Vannucchi, Alessandro Maria
    Guglielmelli, Paola
    HEMATOLOGICAL ONCOLOGY, 2018, 36 (01) : 357 - 359
  • [6] Regulation of Ruxolitinib on matrix metalloproteinase in JAK2V617F positive myeloproliferative neoplasms cells
    刘贵敏
    China Medical Abstracts(Internal Medicine), 2017, 34 (02) : 121 - 121
  • [7] Targeting PP2A-dependent autophagy enhances sensitivity to ruxolitinib in JAK2V617F myeloproliferative neoplasms
    Charly Courdy
    Loïc Platteeuw
    Charlotte Ducau
    Isabelle De Araujo
    Emeline Boet
    Ambrine Sahal
    Estelle Saland
    Valérie Edmond
    Suzanne Tavitian
    Sarah Bertoli
    Pierre Cougoul
    Fanny Granat
    Laura Poillet
    Caroline Marty
    Isabelle Plo
    Jean-Emmanuel Sarry
    Stéphane Manenti
    Véronique Mansat-De Mas
    Carine Joffre
    Blood Cancer Journal, 13
  • [8] Targeting PP2A-dependent autophagy enhances sensitivity to ruxolitinib in JAK2V617F myeloproliferative neoplasms
    Courdy, Charly
    Platteeuw, Loic
    Ducau, Charlotte
    De Araujo, Isabelle
    Boet, Emeline
    Sahal, Ambrine
    Saland, Estelle
    Edmond, Valerie
    Tavitian, Suzanne
    Bertoli, Sarah
    Cougoul, Pierre
    Granat, Fanny
    Poillet, Laura
    Marty, Caroline
    Plo, Isabelle
    Sarry, Jean-Emmanuel
    Manenti, Stephane
    Mansat-De Mas, Veronique
    Joffre, Carine
    BLOOD CANCER JOURNAL, 2023, 13 (01)
  • [9] JAK2V617F molecular remission in a primary myelofibrosis patient treated with ruxolitinib
    Koehler, Anne
    Hubert, Karolin
    Lange, Thoralf
    Siebolts, Udo
    Wickenhauser, Claudia
    Gopalakrishna, Prashanth
    Niederwieser, Dietger
    Monecke, Astrid
    Al-Ali, Haifa Kathrin
    ANNALS OF HEMATOLOGY, 2015, 94 (11) : 1929 - 1930
  • [10] JAK2V617F molecular remission in a primary myelofibrosis patient treated with ruxolitinib
    Anne Koehler
    Karolin Hubert
    Thoralf Lange
    Udo Siebolts
    Claudia Wickenhauser
    Prashanth Gopalakrishna
    Dietger Niederwieser
    Astrid Monecke
    Haifa Kathrin Al-Ali
    Annals of Hematology, 2015, 94 : 1929 - 1930
12345